Novartis unveiled its long-expected plan to spin off all of its Alcon eye care devices business and launch a share buyback of up to US$5 billion as the company sharpens its focus on prescription drugs, it said on Friday.
from Latest News https://ift.tt/2IBIBIt
Novartis to spin off Alcon, will buy back US$5 billion in shares
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment